Advances in chemotherapy for HER2-negative metastatic breast cancer

H Mukai, M Ito - Chinese Clinical Oncology, 2018 - cco.amegroups.org
Metastatic breast cancer cannot be curable, but significant improvement in overall survival
has been observed with the appearance of new agents. The purpose of treatment is to …

Advances in anti-HER2 therapy in metastatic breast cancer

M Yao, P Fu - Chinese Clinical Oncology, 2018 - cco.amegroups.org
Though most patients with breast cancer are cured, there are still many patients progressed
to metastatic breast cancer (MBC) and some are diagnosed as MBC. Human epidermal …

Practical consensus recommendations regarding the management of HER2 neu positive metastatic breast cancer

M Basade, M Singhal, AK Rathi… - South Asian Journal …, 2018 - thieme-connect.com
Metastatic breast cancer (MBC) is cancer that has spread from the breast to another part of
the body or has come back in another distant location. Treatment options for MBC depend …

[HTML][HTML] Clinical impact of new treatment strategies for HER2-positive metastatic breast cancer patients with resistance to classical anti-HER therapies

M Tapia, C Hernando, MT Martínez, O Burgués… - Cancers, 2023 - mdpi.com
Simple Summary HER2-positive metastatic breast cancer remains a nearly incurable
disease. In this sense, new treatments have been developed in recent years. On the one …

[PDF][PDF] New Developments in Metastatic Breast Cancer: Introduction

HS Rugo - Clinical Roundtable Monograph, 2013 - hematologyandoncology.net
CLINICAL ROUNDTABLE MONOGRAPH used for early-stage disease, including estrogen
receptor status and HER2/neu status.(In the future, we hope to incorporate additional …

Hormone receptor positive, HER2 negative metastatic breast cancer: A systematic review of the current treatment landscape

J Beith, K Burslem, R Bell, N Woodward… - Asia‐Pacific Journal …, 2016 - Wiley Online Library
Endocrine therapy for the treatment of hormone receptor positive, HER2 negative, metastatic
breast cancer is continually evolving. We systematically reviewed phase 2 and 3 …

Optimizing treatment of HER2-positive metastatic breast cancer

AL Jones, B Leyland-Jones - Seminars in oncology, 2004 - Elsevier
The primary goal of therapy for metastatic breast cancer is to improve the outcome for
patients. Ideally, this should be achieved with minimal short-term side effects and without …

[HTML][HTML] Current approaches to the management of Her2-negative metastatic breast cancer

K Gogineni, A DeMichele - Breast Cancer Research, 2012 - Springer
While metastatic breast cancer (MBC) remains incurable, a vast array of active therapeutic
agents has provided the opportunity for long-term disease control while maintaining quality …

[HTML][HTML] Combination of cytotoxic drugs for patients with HER2-negative metastatic breast cancer

C De Angelis, M Milano, B Stanzione… - Combination Products in …, 2013 - Springer
In the last few decades the approach to metastatic breast cancer (MBC) treatment using
chemotherapy, either as single or combination agents, has been largely studied and a wide …

[HTML][HTML] Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer

DA Yardley, PA Kaufman, A Brufsky, MU Yood… - Breast cancer research …, 2014 - Springer
Improvements in screening and adjuvant therapy for breast cancer are associated with
decreased recurrence, which may have the effect of increasing the proportion of patients …